HomeAI · summaries
Storia in 2 fonti
Lupin gets tentative US FDA nod for Enzalutamide tablets
Lupin receives tentative US FDA approval for Enzalutamide Tablets, offering new dosing options as a bioequivalent to Xtandi.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
thehindubusinessline.com
Lupin gets tentative US FDA nod for Enzalutamide tablets
Lupin receives tentative US FDA approval for Enzalutamide Tablets, offering new dosing options as a bioequivalent to Xtandi.
- ·
economictimes.indiatimes.com
Lupin gets USFDA tentative approval for prostate cancer treatment drug
Indian pharmaceutical giant Lupin Ltd has secured tentative approval from the US FDA for its generic enzalutamide tablets, a crucial treatment for advanced prostate cancer. This…